An interventional study of Assessment of IL-6 and Biochemical Assessment in Septic Shock, sponsored by New Valley University. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by New Valley University · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this study is to compare between IL 6 versus lactate level for early prediction and prognosis over the first two days or 48 hours of ICU stay in patients with septic shock.
1,082 studies on the registry are indexed under Shock, Septic; 233 are open to participants now.
This study's planned enrollment of 2 is below the median of 80 across 636 interventional studies indexed under Shock, Septic.
Browse Shock, Septic studies →New Valley University is the lead sponsor of 26 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:• Adult patients aged ≥18 years.
Exclusion Criteria:• Pregnancy.
The patients will have blood drawn on day 1 and day 2 of their stay in the ICU. The samples will be processed immediately;
Diagnostic Test: Assessment of IL-6
Fasting blood samples will be drawn from ICU patients by venepuncture after the hemodynamic stabilization phase of admission and after 2 days of being in the ICU to measure renal function (ions and creatinine), liver function (bilirubin), nutritional parameters (folic acid, B12 and copper), hematimetric \[hemoglobin, leukocytes, platelets, INR and activated partial thromboplastin time (APTT)\] and inflammatory parameters \[lactic acid, fibrinogen, lactate dehydrogenase (LDH)\].
Diagnostic Test: Biochemical Assessment
they will be centrifuged at 3500 rpm for 10 min at 4 ◦C and frozen at -80 ◦C..
Fasting blood samples will be drawn from ICU patients by venepuncture after the hemodynamic stabilization phase of admission and after 2 days of being in the ICU to measure renal function (ions and creatinine), liver function (bilirubin), nutritional parameters (folic acid, B12 and copper), hematimetric \[hemoglobin, leukocytes, platelets, INR and activated partial thromboplastin time (APTT)\] and inflammatory parameters \[lactic acid, fibrinogen, lactate dehydrogenase (LDH)\]. PCR and PCT will be performed by the hospital laboratory using standard techniques.
• Correlation between IL-6 and lactic acid.
Time frame: 90 days
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Feb 2027, 2 months later.
Of 164 non-industry interventional studies with no phase under Shock, Septic, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 41. This study's planned 2 months is below that.
Counting every sponsor, half of 172 studies reached it within 25 months; a quarter within 12 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
New Valley University